Brief: Terns Pharmaceuticals Q1 Net Income USD -22.373 Million Vs. IBES Estimate USD -24.8 Million
13/05/2024 13:05
May 13 (Reuters) - Terns Pharmaceuticals Q1 basic EPS USD -0.3. * Q1 income from operations USD -25.446 million vs. IBES estimate USD -27 million * Q1 operating expenses USD 25.446 million * Q1 pretax profit USD -22.276 million vs. IBES estimate USD -24.8 million
Recent news on Terns Pharmaceuticals
See all newsNASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. RESEARCH ROUNDUP-East West Bancorp, Reliance, S&P Global
Brief: Merck Announces Expiration Of Hart-Scott-Rodino Act Waiting Period To Acquire Terns Pharmaceuticals
Brief: Merck Begins Tender Offer To Acquire Terns Pharmaceuticals, Inc.